Telix Pharmaceuticals Limited (TLX)
Healthcare • Biotechnology
StockNasdaqGSAustraliaUS87961M1053
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Telix Pharmaceuticals Limited, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:49. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 803.8M | +55.6% | -7.1M | -0.9% | -0.02 | -121.6% | -61.1M |
| 2024 | 516.6M | +55.1% | 33.7M | 6.5% | 0.10 | +789.8% | 5.3M |
| 2023 | 333M | +205.7% | 4.2M | 1.3% | 0.01 | +104.8% | 7.2M |
| 2022 | 108.9M | — | -70.8M | -65.0% | -0.23 | — | -52.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 9.75 | 9.96 | 9.20 | 9.20 | -4.47% | 1,118,144 | |
| 02 Nov 2026 – 06 Nov 2026 | 9.17 | 9.87 | 9.00 | 9.63 | +5.82% | 1,603,200 | |
| 26 Oct 2026 – 30 Oct 2026 | 9.00 | 9.60 | 8.91 | 9.10 | -0.55% | 1,339,600 | |
| 19 Oct 2026 – 23 Oct 2026 | 10.71 | 11.24 | 9.11 | 9.15 | -14.41% | 2,576,100 | |
| 12 Oct 2026 – 16 Oct 2026 | 11.30 | 11.39 | 10.43 | 10.69 | -4.64% | 1,380,200 | |
| 05 Oct 2026 – 09 Oct 2026 | 10.80 | 11.26 | 10.73 | 11.21 | +6.26% | 1,986,700 | |
| 28 Sep 2026 – 02 Oct 2026 | 11.44 | 11.69 | 10.45 | 10.55 | -7.86% | 2,123,200 | |
| 21 Sep 2026 – 25 Sep 2026 | 11.24 | 12.10 | 10.76 | 11.45 | -9.05% | 3,176,100 | |
| 14 Sep 2026 – 18 Sep 2026 | 12.20 | 13.11 | 11.63 | 12.59 | +11.51% | 2,950,300 | |
| 08 Sep 2026 – 11 Sep 2026 | 12.07 | 12.48 | 11.20 | 11.29 | -5.44% | 1,633,000 | |
| 95 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Talanx Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 12 Nov 2026 11:13
- Telix to Participate in UBS Global Biopharma Conference (opens in a new tab) 11 Nov 2026 07:00
- Telix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeting Theranostics (opens in a new tab) 05 Nov 2026 05:30
- Telix Pharmaceuticals Targets $1.5B Revenue as ITM Deal Speeds Therapy Push (opens in a new tab) MarketBeat · 04 Nov 2026 08:14
- Telix Pharmaceuticals And 2 Other Australian Insider Owned Growth Stocks (opens in a new tab) Simply Wall St. · 16 Oct 2026 10:11
- Profound Medical and Telix Pharmaceuticals Partner to Advance Prostate Cancer Imaging and Treatment Education (opens in a new tab) InvestorsHub · 09 Oct 2026 13:38
- Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How to Trade (opens in a new tab) Zacks · 30 Sep 2026 13:55
- Telix (ASX:TLX) Shares Could Be 42% Undervalued Following Its ITM Deal (opens in a new tab) Simply Wall St. · 23 Sep 2026 20:15
- Telix Pharmaceuticals (ASX:TLX) ITM Deal Puts Valuation Back In Focus (opens in a new tab) Simply Wall St. · 23 Sep 2026 13:13
- Telix (TLX) to Buy Germany’s ITM for up to $2.35 Billion to Lock in its Cancer Isotope Supply (opens in a new tab) Insider Monkey · 22 Sep 2026 23:52
- Telix Pharmaceuticals (ASX:TLX) Lands $2.35 Billion Deal To Reshape Radiopharmaceutical Reach (opens in a new tab) Simply Wall St. · 22 Sep 2026 21:17
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 9.36 USD
- Market cap
- 3.1B
- Exchange
- NasdaqGS
- Country
- Australia
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow TLX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.